180 related articles for article (PubMed ID: 27391438)
1. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.
Yu JI; Lee H; Park HC; Choi DH; Choi YL; Do IG; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Park YS; Park JO; Kim ST; Park W
Oncotarget; 2016 Sep; 7(38):62676-62686. PubMed ID: 27391438
[TBL] [Abstract][Full Text] [Related]
2. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
[TBL] [Abstract][Full Text] [Related]
3. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
Kim J; Ahn S; Kim K; Cho MS; Kim KH; Lee RA; Nam EM
Anticancer Res; 2018 Dec; 38(12):6881-6889. PubMed ID: 30504405
[TBL] [Abstract][Full Text] [Related]
5. [Influence and significance of preoperative intraarterial infusion chemotherapy combined with radiotherapy on survivin, p53 and Bax expression in low rectal carcinoma].
Gan JL; Guo Y; Tang ZJ; Gao F; Tang WZ; Liu XJ
Ai Zheng; 2006 Nov; 25(11):1423-7. PubMed ID: 17094914
[TBL] [Abstract][Full Text] [Related]
6. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.
Huh JW; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim HC; Park HC; Choi DH; Park JO; Park YS; Chun HK
Yonsei Med J; 2015 Jan; 56(1):82-8. PubMed ID: 25510750
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy.
Wiggenraad R; Tamminga R; Blok P; Rouse R; Hermans J
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):29-35. PubMed ID: 9588914
[TBL] [Abstract][Full Text] [Related]
9. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
10. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years.
Wang L; Li YH; Cai Y; Zhan TC; Gu J
Clin Colorectal Cancer; 2016 Jun; 15(2):152-7. PubMed ID: 26508595
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
12. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
13. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
15. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
[TBL] [Abstract][Full Text] [Related]
16. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers.
Peng JJ; Cai SJ; Lu HF; Cai GX; Lian P; Guan ZQ; Wang MH; Xu Y
World J Gastroenterol; 2007 Jun; 13(21):3009-15. PubMed ID: 17589956
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]